Harmony Biosciences (HRMY) News Today $29.96 -0.36 (-1.19%) Closing price 04:00 PM EasternExtended Trading$30.24 +0.29 (+0.95%) As of 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Harmony Biosciences's Earnings: A PreviewMay 5 at 6:23 PM | benzinga.comAquatic Capital Management LLC Buys Shares of 11,127 Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Aquatic Capital Management LLC bought a new position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 11,127 shares of the company's stock, valued at approxMay 5 at 4:43 AM | marketbeat.comWells Fargo & Company MN Reduces Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Wells Fargo & Company MN trimmed its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 84.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,005 shares of the compaMay 5 at 3:15 AM | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Rating of "Buy" from AnalystsShares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) have been given an average rating of "Buy" by the nine research firms that are presently covering the company, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy rating. The average twMay 4 at 2:58 AM | marketbeat.comQ1 EPS Estimate for Harmony Biosciences Reduced by AnalystHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) - HC Wainwright cut their Q1 2025 EPS estimates for shares of Harmony Biosciences in a report released on Monday, April 28th. HC Wainwright analyst P. Trucchio now anticipates that the company will post earnings per share of $0.78 forMay 3 at 6:49 AM | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Position Reduced by PDT Partners LLCPDT Partners LLC decreased its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 50.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,712 shares of the company's stoMay 3 at 5:53 AM | marketbeat.comFirst Trust Advisors LP Boosts Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)First Trust Advisors LP increased its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 255.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 169,409 shares of the comMay 3 at 4:02 AM | marketbeat.comQ1 EPS Forecast for Harmony Biosciences Lowered by AnalystMay 3 at 1:29 AM | americanbankingnews.comConnors Investor Services Inc. Makes New $2.50 Million Investment in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Connors Investor Services Inc. bought a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 72,692 shares of the company's stock,May 2 at 7:33 AM | marketbeat.com18,560 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Bought by Nebula Research & Development LLCNebula Research & Development LLC acquired a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 18,560 shares of theMay 1, 2025 | marketbeat.comUBS Group Lowers Harmony Biosciences (NASDAQ:HRMY) Price Target to $48.00UBS Group decreased their price target on shares of Harmony Biosciences from $55.00 to $48.00 and set a "buy" rating on the stock in a research note on Monday.April 30, 2025 | marketbeat.comBarclays PLC Has $3.47 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Barclays PLC grew its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 31.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 100,872 shares of the company's stock after purchasing an additional 24,010 sharesApril 30, 2025 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Given New $48.00 Price Target at UBS GroupApril 30, 2025 | americanbankingnews.comHarmony Biosciences to Report First Quarter 2025 Financial Results on May 6, 2025April 29, 2025 | businesswire.comAdage Capital Partners GP L.L.C. Purchases 200,000 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Adage Capital Partners GP L.L.C. raised its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 66.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 500,000 shares of the company's stApril 29, 2025 | marketbeat.comDark Forest Capital Management LP Takes $536,000 Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Dark Forest Capital Management LP bought a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 15,57April 28, 2025 | marketbeat.comLegal & General Group Plc Grows Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Legal & General Group Plc lifted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 27.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 116,959 shares of the company's stock after purchasing an additional 25,338 shares duApril 25, 2025 | marketbeat.comHarmony Biosciences (HRMY) Projected to Post Quarterly Earnings on TuesdayHarmony Biosciences (NASDAQ:HRMY) will be releasing its Q1 2025 earnings before the market opens on Tuesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-4-29-harmony-biosciences-holdings-inc-stock/)April 24, 2025 | marketbeat.comFirst Week of June 20th Options Trading For Harmony Biosciences Holdings (HRMY)April 24, 2025 | nasdaq.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Sees Significant Decline in Short InterestHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) was the recipient of a significant decline in short interest in March. As of March 31st, there was short interest totalling 3,490,000 shares, a decline of 15.1% from the March 15th total of 4,110,000 shares. Approximately 8.0% of the shares of the stock are short sold. Based on an average trading volume of 683,500 shares, the days-to-cover ratio is presently 5.1 days.April 23, 2025 | marketbeat.comInvesco Ltd. Raises Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Invesco Ltd. increased its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 173.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 449,180 shares of the company's stock after buyiApril 22, 2025 | marketbeat.comHarmony Biosciences price target lowered to $32 from $33 at BofAApril 22, 2025 | markets.businessinsider.comBank of America Securities Sticks to Its Sell Rating for Harmony Biosciences Holdings (HRMY)April 22, 2025 | markets.businessinsider.comMarshall Wace LLP Has $31.99 Million Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Marshall Wace LLP lifted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 165.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 929,744 shares of the company's stockApril 21, 2025 | marketbeat.comGeode Capital Management LLC Has $31.08 Million Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Geode Capital Management LLC increased its holdings in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 22.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 902,934 shares of the company's stoApril 19, 2025 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Stock Price Down 4.6% - Here's What HappenedHarmony Biosciences (NASDAQ:HRMY) Stock Price Down 4.6% - What's Next?April 17, 2025 | marketbeat.comFmr LLC Buys 101,182 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Fmr LLC boosted its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 1.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,329,902 shares of the company's stockApril 15, 2025 | marketbeat.comRenaissance Technologies LLC Grows Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Renaissance Technologies LLC lifted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 15.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 568,671 shares of the company's stockApril 15, 2025 | marketbeat.comLSV Asset Management Buys 184,026 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)LSV Asset Management lifted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 23.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 956,217 shares of the cApril 14, 2025 | marketbeat.comFederated Hermes Inc. Sells 49,276 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Federated Hermes Inc. cut its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 9.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 492,803 shares of the company's stApril 12, 2025 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Receives Buy Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $70.00 target price on shares of Harmony Biosciences in a research report on Tuesday.April 10, 2025 | marketbeat.comNeedham & Company LLC Reiterates Buy Rating for Harmony Biosciences (NASDAQ:HRMY)Needham & Company LLC reaffirmed a "buy" rating and set a $50.00 price target on shares of Harmony Biosciences in a research note on Tuesday.April 10, 2025 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Sets New 52-Week Low - Should You Sell?Harmony Biosciences (NASDAQ:HRMY) Sets New 52-Week Low - Here's What HappenedApril 9, 2025 | marketbeat.comNorges Bank Invests $16.12 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Norges Bank acquired a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 468,410 shares of the company's stock, valued at approximately $16April 9, 2025 | marketbeat.com6HRMY : Breaking Down Harmony Biosciences...April 8, 2025 | benzinga.comHarmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X SyndromeApril 8, 2025 | finance.yahoo.comHarmony Biosciences Appoints Ron Philip to Board of DirectorsApril 8, 2025 | msn.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Acquired by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA increased its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 25.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 829,620 shareApril 8, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Holdings Increased by Vanguard Group Inc.Vanguard Group Inc. boosted its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 36.4% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,733,609 shares of the company's stock after purchasing an aApril 8, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Consensus Recommendation of "Buy" by AnalystsHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) has been given a consensus recommendation of "Buy" by the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a buy recommendation. The average 1-yApril 8, 2025 | marketbeat.comTrexquant Investment LP Makes New Investment in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Trexquant Investment LP acquired a new stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 175,574 shares of the company's stock, valued at approximately $6,042,000. TrexquaApril 7, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Has $10.21 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Arrowstreet Capital Limited Partnership reduced its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 6.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 296,618 shApril 7, 2025 | marketbeat.comPrudential Financial Inc. Buys 28,650 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Prudential Financial Inc. raised its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 91.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 59,911 shares of the company's stock after buying aApril 6, 2025 | marketbeat.comRaymond James Financial Inc. Invests $1.30 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Raymond James Financial Inc. purchased a new stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 37,907 shares of the company's stock, valued at approximately $1,April 4, 2025 | marketbeat.comHarmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of DirectorsApril 3, 2025 | businesswire.comKLP Kapitalforvaltning AS Invests $791,000 in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)KLP Kapitalforvaltning AS purchased a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 23,000 shares of theApril 2, 2025 | marketbeat.comHighTower Advisors LLC Has $392,000 Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)HighTower Advisors LLC reduced its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 85.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,401 shares of the coApril 2, 2025 | marketbeat.com49,632 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Bought by New Age Alpha Advisors LLCNew Age Alpha Advisors LLC acquired a new stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 49,632 shares of the compaApril 1, 2025 | marketbeat.comHarmony Biosciences to Present at 24th Annual Needham Virtual Healthcare ConferenceMarch 31, 2025 | msn.comAmerican Century Companies Inc. Increases Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)American Century Companies Inc. grew its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 28.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,102,604 shares of theMarch 29, 2025 | marketbeat.com Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address HRMY Media Mentions By Week HRMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HRMY News Sentiment▼1.100.72▲Average Medical News Sentiment HRMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HRMY Articles This Week▼186▲HRMY Articles Average Week Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TG Therapeutics News Legend Biotech News Sarepta Therapeutics News Telix Pharmaceuticals Limited American Depositary Shares News ADMA Biologics News Blueprint Medicines News Verona Pharma News Nuvalent News Axsome Therapeutics News Grifols News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HRMY) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harmony Biosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harmony Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
